Rybelsus: oral semaglutide
Rybelsus is the brand name for oral semaglutide manufactured by Novo Nordisk, approved for type 2 diabetes treatment. It is the first oral formulation of a GLP-1 receptor agonist.
Brand notice: NoGuiltMeds is not affiliated with the manufacturers of these medications. Trademarks mentioned belong to their respective owners. Compounded products are not equivalent to FDA-approved brand-name products.
Frequently asked questions
Does Rybelsus help with weight loss?
Rybelsus is approved for type 2 diabetes. Higher-dose oral semaglutide for weight management is in development or approval.
What is the difference between Rybelsus and Ozempic?
Both contain semaglutide, but Rybelsus is oral (daily pill) and Ozempic is injectable (weekly).
You might also like
Online medical evaluation
Ready to start? The evaluation is free.
A licensed provider reviews every case. If you qualify, your plan can start from $99.
Start evaluation